GlassScriptPhysician profile
Brian E Christofferson
NPI 1770522948
$1,939.48
in general payments reported to CMS, 2019-2025
12 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $440 · 2023: $309 · 2024: $380 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $637.39 | 2021-2025 | Vanta Adaptivestim, Synchromedii, Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $415.51 | 2021-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $342.64 | 2021-2025 | Relistor |
| Abbvie INC. | $187.76 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $95.39 | 2022 | |
| Biodelivery Sciences International, INC. | $84.98 | 2021 | |
| Valinor Pharma, LLC | $61.00 | 2025 | Movantik |
| Uswm, LLC | $31.29 | 2021-2022 | |
| Almatica Pharma LLC | $26.34 | 2023 | Gralise |
| Vertex Pharmaceuticals Incorporated | $23.64 | 2025 | |
| Ardelyx, INC. | $19.07 | 2022 | |
| Hikma Pharmaceuticals USA | $14.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Christofferson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.